The Medicalization of Grief

Determining where normal human emotion ends and mental disorder begins remains one of psychiatry’s most contested challenges. Grief, a universal yet deeply individualized response to loss, sits at the center of this debate. As medicalization increasingly frames everyday suffering as pathology, the boundaries of mental illness have expanded, running the risk of transforming ordinary emotional experiences into diagnosable conditions. While this process can legitimize distress and improve access to care, it also risks reducing complex, socially embedded experiences to clinical symptoms. The shifting classification of grief within the Diagnostic and Statistical Manual of Mental Disorders illustrates this tension. The removal of the bereavement exclusion in DSM-5 and the subsequent introduction of Prolonged Grief Disorder in DSM-5-TR reflect evolving and socially negotiated diagnostic criteria. These changes blur distinctions between natural mourning and more severe mental disorders, raising concerns about overdiagnosis and the imposition of rigid temporal and functional standards on an experience shaped by culture, relationship, and meaning. Grief varies widely in expression, duration, and intensity across individuals and societies. Pathologizing it risks reinforcing Western ideals of productivity, emotional restraint, and rapid recovery while neglecting communal, moral, and existential dimensions of loss. Although some individuals experience debilitating grief that warrants clinical intervention, most mourning is not a disorder to be cured but a meaningful process to be lived. A cautious, context-sensitive, and culturally attuned approach is essential to preserve the integrity of grief while still supporting those whose suffering becomes disabling.